Clinical Trials

33 enrolled

Advanced Colorectal Cancer

NCT07391618 2026-02-06

Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU

583 enrolled

Advanced Colorectal Cancer

NCT07281157 2025-12-30

Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer

30 enrolled

Phase 3 Active not recruiting

Advanced Colorectal Cancer

NCT06199973 2025-07-17

Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan

130 enrolled

Advanced Colorectal Cancer

NCT06885385 2025-06-24

A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer

60 enrolled

Phase 2 Not yet recruiting

Advanced Colorectal Cancer

NCT07000305 2025-06-02

SUPβORT

42 enrolled

Phase 2 Not yet recruiting

Advanced Colorectal Cancer

NCT06838546 2025-02-20

A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer

80 enrolled

Phase EARLY_PHASE1 Recruiting

Advanced Colorectal Cancer

NCT06446050 2024-06-06

Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer

30 enrolled

Advanced Colorectal Cancer

NCT06200363 2024-01-11

A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer

Phase 1 Unknown

15 enrolled

Phase NA Not yet recruiting

Advanced Colorectal Cancer

NCT05963087 2023-07-27

Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer

22 enrolled

Phase NA Not yet recruiting

Advanced Colorectal Cancer

NCT05928312 2023-07-20

Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

72 enrolled

Advanced Colorectal Cancer

NCT02619435 2023-03-24

STREAM

46 enrolled

Advanced Colorectal Cancer

NCT05495672 2022-08-10

Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules

Phase NA Unknown

100 enrolled

Phase 2 Not yet recruiting

Advanced Colorectal Cancer

NCT05364489 2022-05-20

Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer

20 enrolled

Advanced Colorectal Cancer

NCT04835324 2022-03-11

Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study

Unknown

650 enrolled

Advanced Colorectal Cancer

NCT04764006 2021-11-04

Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study

10 enrolled

Advanced Colorectal Cancer

NCT02826837 2021-10-06

LEAC-102 for Advanced Colorectal Cancer

Phase 1/2 Unknown

30 enrolled

Advanced Colorectal Cancer

NCT03126071 2021-08-30

Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

100 enrolled

Advanced Colorectal Cancer

NCT04324476 2021-08-30

A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer

50 enrolled

Advanced Colorectal Cancer

NCT02227667 2021-06-18

Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer

16 enrolled 9 charts

Advanced Colorectal Cancer

NCT04929652 2021-06-18

Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer

Phase 1/2 Unknown

48 enrolled

Advanced Colorectal Cancer

NCT03311750 2021-06-07

A-REPEAT

Phase 2 Terminated

23 enrolled

Advanced Colorectal Cancer

NCT03427268 2021-05-24

Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment

32 enrolled 22 charts

Advanced Colorectal Cancer

NCT04734249 2021-02-02

Second-line Surufatinib Combined With Chemotherapy in Advanced CRC

56 enrolled

Advanced Colorectal Cancer

NCT00637091 2021-01-22

Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions

40 enrolled

Advanced Colorectal Cancer

NCT04337879 2020-07-21

A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer

Phase 1/2 Unknown

56 enrolled

Advanced Colorectal Cancer

NCT04252456 2020-02-05

DISTINCTIVE

Phase NA Unknown

150 enrolled

Advanced Colorectal Cancer

NCT00309179 2017-09-14

A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

41 enrolled

Advanced Colorectal Cancer

NCT02923622 2016-10-04

Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer

Unknown

384 enrolled

Advanced Colorectal Cancer

NCT00598247 2014-02-06

A Pilot Study of PPX in Women With Metastatic Colorectal Cancer

Phase 1 Completed

15 enrolled

Advanced Colorectal Cancer

NCT00824161 2012-04-23

Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer

Phase 2 Terminated

28 enrolled 8 charts

Advanced Colorectal Cancer

NCT00972465 2009-09-07

Study of Nimotuzumab to Treat Colorectal Cancer

48 enrolled

Advanced Colorectal Cancer

NCT00286000 2007-12-28

High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study

106 enrolled